AC Immune (ACIU) Other Working Capital Changes (2017 - 2024)
AC Immune (ACIU) posted quarterly Other Working Capital Changes of -$18264.3 for Q4 2024, up 91.9% year-over-year from -$9517.7 in Q1 2024, and up 45.43% quarter-over-quarter from -$33472.0 in Q3 2024.
AC Immune (ACIU) Other Working Capital Changes (2017 - 2024) Analysis & Trends
AC Immune (ACIU) has reported Other Working Capital Changes for 8 consecutive years, with -$18264.3 the latest figure, recorded in Q4 2024.
- In Q4 2024, Other Working Capital Changes rose 91.9% year-over-year to -$18264.3; the TTM figure through Dec 2024 stood at -$157128.0 (up 68.51% YoY), while the FY2024 annual figure was -$157530.0, up 68.88% from the prior year.
- Other Working Capital Changes improved to -$18264.3 in Q4 2024 per ACIU's latest filing, from -$33472.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.9 million in Q1 2024 and bottomed at -$1.6 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$5800.5 across 5 years, with a median of $130557.6 in 2022.
- Annual changes were most pronounced in 2020 — Other Working Capital Changes sank 569.5% — and 2022, when it jumped 156.81%.
- AC Immune's Other Working Capital Changes stood at -$346550.6 in 2020, then climbed by 20.17% to -$276638.8 in 2021, then surged by 137.06% to $102510.2 in 2022, then plunged by 319.95% to -$225470.9 in 2023, then surged by 91.9% to -$18264.3 in 2024.
- Business Quant data shows ACIU's Other Working Capital Changes at -$18264.3 in Q4 2024, -$33472.0 in Q3 2024, and -$32068.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -18,264.35 |
| Dec 31, 2024 | -18,264.35 |
| Dec 31, 2024 | -18,264.35 |
| Sep 30, 2024 | -33,472.01 |
| Sep 30, 2024 | -33,472.01 |
| Sep 30, 2024 | -33,472.01 |
| Jun 30, 2024 | -32,068.01 |
| Jun 30, 2024 | -32,068.01 |
| Jun 30, 2024 | -32,068.01 |
| Mar 31, 2024 | -73,323.67 |
| Mar 31, 2024 | -73,323.67 |
| Mar 31, 2024 | -73,323.67 |
| Dec 31, 2023 | -225,470.89 |
| Dec 31, 2023 | -225,470.89 |
| Dec 31, 2023 | -225,470.89 |
| Sep 30, 2023 | -104,158.04 |
| Sep 30, 2023 | -104,158.04 |
| Sep 30, 2023 | -104,158.04 |
| Jun 30, 2023 | 16,682.63 |
| Jun 30, 2023 | 16,682.63 |